
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Oncology, Markers, Clinical Correlates |
Departments of Gynecologic Oncology [M. B., C. G. T., G. B. K.] and Pathology [R. H., J. M. N.], The Norwegian Radium Hospital, Montebello, 0310 Oslo, Norway
The eukaryotic cell cycle is controlled by protein complexes consisting of cyclin-dependent kinases and cyclins. The cyclin-dependent kinases are in turn negatively regulated by a family of cyclin-dependent kinase inhibitors, comprising, among others, the p21 and p27 proteins. p21 and p27 have been shown to be of prognostic significance in a broad array of human tumors. Using immunohistochemistry, the frequency of expression and the possible prognostic and predictive significance of these proteins were examined in a series of 185 uniformly treated patients with stage III ovarian cancer. We found p21 to be overexpressed in 48% of cases. No significant correlation was found between the expression of p21 and p53 proteins (P = 0.273). A low level of p27 was demonstrated in 48.5% of cases. p21 overexpression correlated with lower Fédération Internationale des Gynaecologistes et Obstetristes substage, lower patient age, and absence of ascites, but neither p21 nor p27 expression was of prognostic significance for the whole group of patients. Only a trend toward reduced survival (P = 0.092) was noticed for the small subgroup of patients (6%), whose tumors lacked p27 expression completely. A clear positive correlation could be found between p21 and p27 protein expression (P = 0.012). Despite the suggested role of the 21 and p27 proteins in determining drug sensitivity, they were not found to be predictive for response to chemotherapy, as assessed by second-look laparotomy in this large group of patients with advanced ovarian cancer.
This article has been cited by other articles:
![]() |
A. Psyrri, A. Bamias, Z. Yu, P. M. Weinberger, M. Kassar, S. Markakis, D. Kowalski, E. Efstathiou, R. L. Camp, D. L. Rimm, et al. Subcellular Localization and Protein Levels of Cyclin-Dependent Kinase Inhibitor p27 Independently Predict for Survival in Epithelial Ovarian Cancer Clin. Cancer Res., December 1, 2005; 11(23): 8384 - 8390. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G. Rosen, G. Yang, K. Q. Cai, R. C. Bast Jr., D. M. Gershenson, E. G. Silva, and J. Liu Subcellular Localization of p27kip1 Expression Predicts Poor Prognosis in Human Ovarian Cancer Clin. Cancer Res., January 15, 2005; 11(2): 632 - 637. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. D'Andrilli, C. Kumar, G. Scambia, and A. Giordano Cell Cycle Genes in Ovarian Cancer: Steps Toward Earlier Diagnosis and Novel Therapies Clin. Cancer Res., December 15, 2004; 10(24): 8132 - 8141. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bali, P. M. O'Brien, L. S. Edwards, R. L. Sutherland, N. F. Hacker, and S. M. Henshall Cyclin D1, p53, and p21Waf1/Cip1 Expression Is Predictive of Poor Clinical Outcome in Serous Epithelial Ovarian Cancer Clin. Cancer Res., August 1, 2004; 10(15): 5168 - 5177. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Plisiecka-Halasa, G. Karpinska, T. Szymanska, I. Ziolkowska, R. Madry, A. Timorek, J. Debniak, M. Ulanska, M. Jedryka, A. Chudecka-Glaz, et al. P21WAF1, P27KIP1, TP53 and C-MYC analysis in 204 ovarian carcinomas treated with platinum-based regimens Ann. Onc., July 1, 2003; 14(7): 1078 - 1085. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Rose, M. J. Goodheart, B. R. DeYoung, B. J. Smith, and R. E. Buller p21 Expression Predicts Outcome in p53-null Ovarian Carcinoma Clin. Cancer Res., March 1, 2003; 9(3): 1028 - 1032. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Masciullo, G. Ferrandina, B. Pucci, F. Fanfani, S. Lovergine, J. Palazzo, G. Zannoni, S. Mancuso, G. Scambia, and A. Giordano p27Kip1 Expression Is Associated with Clinical Outcome in Advanced Epithelial Ovarian Cancer: Multivariate Analysis Clin. Cancer Res., December 1, 2000; 6(12): 4816 - 4822. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |